Company news

Traws Pharma, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Onconova Therapeutics to Provide Corporate Update and Announce Third Quarter 2023 Financial Results on November 14, 2023

November 6, 2023

Encouraging Rigosertib Data Presented at EADV as Late Breaker

October 11, 2023

Onconova Therapeutics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference

September 5, 2023

Onconova Therapeutics to Provide Corporate Update and Announce Second Quarter 2023 Financial Results on August 10, 2023

August 2, 2023

Onconova Therapeutics Presents Preclinical Data on Narazaciclib at the 17th International Conference on Malignant Lymphoma

June 13, 2023

Onconova Therapeutics Announces Dosing of First Participant in Investigator-Sponsored Phase 2 Trial of Rigosertib Plus Pembrolizumab in Metastatic Melanoma Patients Refractory to Immune Checkpoint Blockade

May 24, 2023

Onconova Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update

May 14, 2023

Onconova Therapeutics to Participate in Ladenburg Thalmann Virtual R&D Showcase on Narazaciclib in Endometrial Cancer

May 11, 2023

Onconova Therapeutics to Provide Corporate Update and Announce First Quarter 2023 Financial Results on May 15, 2023

May 3, 2023

Onconova Therapeutics Announces the Presentation of New Preclinical Data on Narazaciclib at the AACR Annual Meeting

April 18, 2023

Onconova Therapeutics and Pangea Biomed Enter into Research Collaboration to Identify Biomarkers of Response to Rigosertib

March 22, 2023

Onconova Therapeutics Reports Full Year 2022 Financial Results and Provides Business Update

March 15, 2023

Onconova Therapeutics Presents Preclinical Data Characterizing Rigosertib’s Mechanisms of Action at the AACR Targeting RAS Conference

March 6, 2023

Onconova Therapeutics Announces Additional Clinical Data Demonstrating Rigosertib’s Monotherapy Activity in RDEB-Associated Squamous Cell Carcinoma

February 6, 2023

Onconova Therapeutics Appoints Drs. Peter Atadja and Trafford Clarke to its Board of Directors

December 18, 2022

Onconova Therapeutics to Present at the Upcoming MedInvest Oncology Investor Conference

December 6, 2022

Onconova Therapeutics to Present at the Upcoming RHK Capital Disruptive Growth Conference

November 27, 2022

Onconova Therapeutics Announces Plans for a Phase 1/2a Trial of Narazaciclib Combined with Letrozole in Endometrial Cancer, Reports Third Quarter 2022 Financial Results, and Provides a Business Update

November 13, 2022

Onconova Therapeutics to Provide Corporate Update and Announce Third Quarter Financial Results on November 14, 2022

November 6, 2022

Onconova Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference

August 31, 2022

Onconova Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update

August 10, 2022

Onconova Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update

May 10, 2022

← Newer news releases

Calls

Decks

The 5 newest of 14 decks. Every deck is listed under its year.